News | May 20, 2023
Abbott India posts Q4FY23 PAT at Rs. 231.42 Cr
The company has reported total income of Rs. 1392.72 crores during the period ended March 31, 2023
The company has reported total income of Rs. 1392.72 crores during the period ended March 31, 2023
Venlafaxine HCl extended-release capsules are indicated for the treatment of: Major Depressive Disorder
These initiatives aim to improve access to healthcare for rare disease patients
Concept Medical’s manufacturing arm has reduced its carbon footprint via in-house efficiency improvement programmes & green infrastructure
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
The collaboration between CORONA and Ferring will cater to patients across India
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
The receipt of this permission paves way for the launch of Trastuzumab deruxtecan (Enhertu) solution of 100mg/5mL in India
CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology
Subscribe To Our Newsletter & Stay Updated
